Cardinal Health (NYSE: CAH), a global, integrated healthcare services and products company, has named Sheri Edison as its new independent director, effective 1 September, it was reported on Monday.
Presently, Edison holds the position of executive vice president and general counsel for Amcor plc. She has also served as senior vice president, chief legal officer and secretary for Bemis Company Inc, and senior vice president, chief administrative officer of Hill-Rom Holdings Inc and in multiple senior legal roles at other leading companies, and as an attorney in private practice. Edison also serves on the board of directors for American Family Insurance and on the Board of Visitors of the University of Wisconsin Waisman Center. She has also served on the board of directors of AK Steel, where she chaired the Nominating and Corporate Governance Committee.
Gregory Kenny, chairman of the board for Cardinal Health, said, 'We are very pleased to welcome Sheri as a director. Sheri brings both strong leadership experience across areas of legal and regulatory compliance and corporate governance as well as a healthcare industry background that complement the experiences and skillsets of our current directors. She has led a number of critical business functions and initiatives, including IT and strategic planning efforts during her career, and we look forward to benefitting from her deep expertise and knowledge of complex businesses.'
BioCare climbs 1,145 places on Inc. 5000 list
DuPont recognised with R&D 100 Award for innovation in healthcare
Synaptiq Therapeutics launches and acquires clinical-stage SYN-001 programme
WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture